{"id":20247,"date":"2021-02-11T12:37:01","date_gmt":"2021-02-11T12:37:01","guid":{"rendered":"https:\/\/celonpharma.com\/?page_id=20247"},"modified":"2025-04-04T16:23:09","modified_gmt":"2025-04-04T14:23:09","slug":"current-reports","status":"publish","type":"page","link":"https:\/\/celonpharma.com\/en\/current-reports\/","title":{"rendered":"Current reports"},"content":{"rendered":"\n\t<form method='get'>\n\t\t<div class='grid-x grid-margin-x grey current-reports'>\n\t\t  <div class='large-4 cell'>\n\t\t      <div class='grid-x'>\n\t\t          <div class='auto cell'>\n\t\t              <label>Choose year:<\/label>\n\t\t          <\/div>\n\t\t          <div class='auto cell'>\n\t\t\t\t\t\t\t\t\t<select name='report-year'>\n\t\t\t\t\t\t\t\t\t\t<option value=''>--Choose year--<\/option><option value='2026'selected>2026<\/option><option value='2025'>2025<\/option><option value='2024'>2024<\/option><option value='2023'>2023<\/option><option value='2022'>2022<\/option><option value='2021'>2021<\/option>\n\t\t\t\t\t\t\t\t\t<\/select>\n\t\t          <\/div>\n\t\t      <\/div>\n\t\t  <\/div>\n\n\t\t  <div class='large-6 cell'>\n\t\t      <div class='grid-x grid-margin-x'>\n\t\t          <div class='auto cell'>\n\t\t              <label>and reports numbers<\/label>\n\t\t          <\/div>\n\t\t          <div class='auto cell'>\n\t\t              <input type='number' value='' name='report-from' placeholder='from' \/>\n\t\t          <\/div>\n\t\t          <div class='auto cell'>\n\t\t              <input type='number' value='' name='report-to' placeholder='to' \/>\n\t\t          <\/div>\n\t\t      <\/div>\n\t\t  <\/div>\n\t\t  <div class='large-2 cell'>\n\t\t      <button type='submit' class='button expanded orange'>Show<\/button>\n\t\t  <\/div>\n\t\t<\/div>\n\t<\/form>\n\t<div class='archive raports'>\n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-9-2026-execution-of-an-agreement-with-pharmalink-for-the-commercialization-of-reduzek-semaglutide-in-selected-gulf-countries\/'>Current report no 9\/2026 &#8211; Execution of an Agreement with Pharmalink for the Commercialization of Reduzek (semaglutide) in Selected Gulf Countries<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-06-08<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-8-2026-allocation-of-series-a-subscription-warrants-to-eligible-participants-under-the-management-incentive-program\/'>Current Report No. 8\/2026 &#8211; Allocation of Series A Subscription Warrants to Eligible Participants under the Management Incentive Program<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-06-03<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-7-2026-notice-of-convening-the-annual-general-meeting-of-celon-pharma-s-a-on-june-24-2026-together-with-draft-resolutions\/'>Current Report No. 7\/2026 &#8211; Notice of Convening the Annual General Meeting of Celon Pharma S.A. on June 24, 2026, Together with Draft Resolutions<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-05-29<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-6-2026-four-celon-pharma-s-a-projects-selected-for-funding-under-a-competition-announced-by-the-medical-research-agency\/'>Current Report No. 6\/2026 &#8211; Four Celon Pharma S.A. Projects Selected for Funding under a Competition Announced by the Medical Research Agency<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-05-06<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-5-2026-execution-of-amendments-to-agreements-concerning-cooperation-with-tang-capital\/'>Current report 5\/2026 &#8211; Execution of Amendments to Agreements Concerning Cooperation with Tang Capital<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-03-16<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-4-2026-execution-of-a-financing-agreement-by-the-issuers-subsidiary-with-the-european-bank-for-reconstruction-and-development\/'>Current Report No. 4\/2026 \u2013 Execution of a Financing Agreement by the Issuer\u2019s Subsidiary with the European Bank for Reconstruction and Development<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-03-09<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-3-2026-resignation-and-appointment-of-a-management-board-member-of-celon-pharma-s-a\/'>Current Report No. 3\/2026 \u2013 Resignation and Appointment of a Management Board Member of Celon Pharma S.A.<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-02-27<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-2-2026-summary-of-the-fda-type-b-meeting-for-cpl36-in-the-treatment-of-levodopa-induced-dyskinesia-in-patients-with-parkinsons-disease-pd-lid\/'>Current Report No. 2\/2026 \u2013 Summary of the FDA Type B Meeting for CPL\u201936 in the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson\u2019s Disease (PD-LID)<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-02-09<\/p>\n\t\t\t\t<\/article>\n\t\t\t \n\t\t\t \t<article class='post raports-current'>\n\t\t\t\t\t\t<h2><a href='https:\/\/celonpharma.com\/en\/current-report-no-1-2026-dates-of-publication-of-periodic-reports-in-2026\/'>Current Report No. 1\/2026 &#8211; Dates of publication of periodic reports in 2026<\/a><\/h2>\n\t\t\t\t\t\t<p>2026-01-26<\/p>\n\t\t\t\t<\/article>\n\t\t\t <\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-20247","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Current reports - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/current-reports\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current reports - Celon Pharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/current-reports\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-04T14:23:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-reports\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-reports\\\/\",\"name\":\"Current reports - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2021-02-11T12:37:01+00:00\",\"dateModified\":\"2025-04-04T14:23:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-reports\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-reports\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-reports\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current reports\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current reports - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/current-reports\/","og_locale":"en_US","og_type":"article","og_title":"Current reports - Celon Pharma","og_url":"https:\/\/celonpharma.com\/en\/current-reports\/","og_site_name":"Celon Pharma","article_modified_time":"2025-04-04T14:23:09+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/current-reports\/","url":"https:\/\/celonpharma.com\/en\/current-reports\/","name":"Current reports - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2021-02-11T12:37:01+00:00","dateModified":"2025-04-04T14:23:09+00:00","breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/current-reports\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/current-reports\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/current-reports\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Current reports"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages\/20247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=20247"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages\/20247\/revisions"}],"predecessor-version":[{"id":20248,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages\/20247\/revisions\/20248"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=20247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}